Cleared Traditional

K062641 - BODY-STIM, BIOMODULATOR, BEST-RSI, BEST PRO, MODEL BEST-AV1

K062641 is an FDA 510(k) clearance for BODY-STIM, manufactured by Avazzia, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 236-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
236d
Days
Class 2
Risk

K062641 is an FDA 510(k) clearance for the BODY-STIM, BIOMODULATOR, BEST-RSI, BEST PRO, MODEL BEST-AV1. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Avazzia, Inc. (Dallas, US). The FDA issued a Cleared decision on April 30, 2007 after a review of 236 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Avazzia, Inc. devices

FDA 510(k) Submission Details - K062641

510(k) Number K062641 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2006
Decision Date April 30, 2007
Days to Decision 236 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 149d · This submission: 236d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 339
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K062641.
LORENZ BIOTECH APTIVA, VERSION 2.13
K061828 · Lorenz Biotech S.P.A. · Aug 2007
EZFIT DIGITAL HEATING TENS (MODEL NO.: HR-661/UC-101)
K070299 · Ezfit Technology, Inc. · Jul 2007
WELLNESSPRO 2010
K062616 · Intelsource Group, Inc. · Jul 2007
NEWLIFE SCIENCES LLC, MODEL TMR
K070474 · Newlife Sciences, LLC · Apr 2007
QUADRA BLOC TENS, MODEL 101
K062547 · Gradient Technologies, LLC · Mar 2007
BODIHEALTH SYSTEM
K052836 · Usa Laser Therapeutics, Inc. · Feb 2007